FFF Enterprises: BioSupply Trends Newsletter
Monday, August 23, 2017

Study Shows Microneedle Patch Influenza Vaccine is Effective
and Painless

 

In this Issue

•  IVIG/Albumin Supply Index
•  Open Market Pricing
•  New Products from FFF
•  Current Medicare
IVIG / SCIG Rates
•  Resources
•  Subscribe to IG Living and BioSupply Trends Quarterly
 

A new study shows that microneedle patches provide an alternative to conventional needle-and-syringe immunization, potentially offering improved immunogenicity, simplicity, cost-effectiveness, acceptability and safety. [ read more ]

Clinical Trial of Universal Flu Vaccine Is a Success

Scientists at the National Institutes of Health (NIH), Frederick National Laboratory for Cancer Research and the University of Melbourne in Australia tested a new universal flu vaccine that produced good immunity against several different strains of influenza viruses. [ read more ]

Coagadex Prevents or Reduces Bleeding in Children with Hereditary Factor X Deficiency

A Phase III study, known as TENO2, conducted in children 12 years and younger with a diagnosis of moderate or severe congenital factor X deficiency and either a history of severe bleeding or an F10 gene mutation causing a documented severe bleeding type, found that Coagadex was effective in preventing bleeding episodes and was well-tolerated and safe. [ read more ]

Industry News

 
 

From ADMA Biologics

ADMA Biologics has acquired Biotest Pharmaceuticals’ Therapy Business Unit, and now owns the marketing rights to Nabi-HB (hepatitis B immune globulin, human) and Bivigam (immune globulin intravenous, human). [ read more ]

From Seqirus

Seqirus has successfully produced a cell-based influenza vaccine using a candidate vaccine virus that has been isolated and grown in cells, rather than in eggs.  [ read more ]

From CSL Behring

CSL Behring has received the National Organization of Rare Disorders’ 2017 Industry Award for IDELVION, its long-acting fusion protein for patients with hemophilia B. [ read more ]

IVIG & Albumin Supply Index

 
 

What's New at FFF

ROCURONIUM BROMIDE (AUROMEDICS PHARMA LLC)

ROCURONIUM BROMIDE (injection) is a nondepolarizing neuromuscular blocking agent indicated as an adjunct to general anesthesia to facilitate both rapid sequence and routine tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is supplied in 50 mg/5 mL and 100 mg/10 mL multiple-dose vials in packages of 10.

For more information about ROCURONIUM BROMIDE,
login to biosupply.fffenterprises.com

These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective July 1, 2017, through Sept. 30, 2017.

Product J Codes ASP + 6%
(before sequester)
ASP + 4.3%*
(after sequester)
IVIG
Carimune NF J1566 $65.88 $64.83
Flebogamma J1572 $55.86 $54.96
Gammagard S/D J1566 $65.88 $64.83
Gammaplex J1557 $93.38 $91.88
Octagam J1568 $68.25 $67.16
Privigen J1459 $77.21 $75.97
SCIG
CUVITRU ** J3490/J3590/J7799 - -
Hizentra J1559 $98.29 $96.71
HyQvia J1575 $130.36 $128.27
IVIG / SCIG
Gammagard Liquid J1569 $80.39 $79.10
Gammaked J1561 $76.82 $75.59
Gamunex-C J1561 $76.82 $75.59

*Reflects 2% sequestration reduction applied to 80% Medicare payment portion as required under Budget Control Act of 2011.

 

Resources

FFF customers may order the following complementary resources to help you with your practice:

•  IG Immune Globulin (Human)
•  Hyperimmune Globulins
•  Anti-Inhibitor, Factor VIIa & IX
•  Factor VIII & von Willebrand Factor
•  Seasonal Influenza Vaccine

Subscribe to IG Living

IG Living is the only magazine for the immune globulin (IG) community for patients who suffer from chronic illness and their caregivers.

Subscribe to BioSupply
Trends Quarterly

BioSupply Trends Quarterly magazine is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace.

Home | About | Advertise | Subscribe | Contact – ©2017 FFF Enterprises, Inc.
This email was sent by: %%Member_Busname%%, %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
Manage preferences: Privacy Policy, Update Profile, Unsubscribe.